Berg A - Search Results

1

Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas.

Haldorsen IS, Berg A, Werner HM, Magnussen IJ, Helland H, Salvesen OO, Trovik J, Salvesen HB. Haldorsen IS, et al. Among authors: berg a. Gynecol Oncol. 2012 Sep;126(3):413-8. doi: 10.1016/j.ygyno.2012.05.009. Epub 2012 May 15. Gynecol Oncol. 2012. PMID: 22609110

2

Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.

Fonnes T, Berg HF, Bredholt T, Edqvist PD, Sortland K, Berg A, Salvesen HB, Akslen LA, Werner HMJ, Trovik J, Tangen IL, Krakstad C. Fonnes T, et al. Among authors: berg a, berg hf. Gynecol Oncol. 2018 Jan;148(1):197-203. doi: 10.1016/j.ygyno.2017.10.025. Epub 2017 Oct 31. Gynecol Oncol. 2018. PMID: 29096882

3

ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.

Werner HM, Berg A, Wik E, Birkeland E, Krakstad C, Kusonmano K, Petersen K, Kalland KH, Oyan AM, Akslen LA, Trovik J, Salvesen HB. Werner HM, et al. Among authors: berg a. Mod Pathol. 2013 Mar;26(3):428-34. doi: 10.1038/modpathol.2012.174. Epub 2012 Oct 19. Mod Pathol. 2013. PMID: 23080032 Free article.

4

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.

Hoivik EA, Kusonmano K, Halle MK, Berg A, Wik E, Werner HM, Petersen K, Oyan AM, Kalland KH, Krakstad C, Trovik J, Widschwendter M, Salvesen HB. Hoivik EA, et al. Among authors: berg a. Oncotarget. 2014 Feb 28;5(4):1052-61. doi: 10.18632/oncotarget.1697. Oncotarget. 2014. PMID: 24658009 Free PMC article.

5

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.

Berg A, Fasmer KE, Mauland KK, Ytre-Hauge S, Hoivik EA, Husby JA, Tangen IL, Trovik J, Halle MK, Woie K, Bjørge L, Bjørnerud A, Salvesen HB, Werner HM, Krakstad C, Haldorsen IS. Berg A, et al. Oncotarget. 2016 Oct 25;7(43):69844-69856. doi: 10.18632/oncotarget.12004. Oncotarget. 2016. PMID: 27634881 Free PMC article.

6

Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers.

Berg A, Gulati A, Ytre-Hauge S, Fasmer KE, Mauland KK, Hoivik EA, Husby JA, Tangen IL, Trovik J, Halle MK, Stefansson I, Akslen LA, Woie K, Bjørge L, Salvesen HB, Salvesen ØO, Werner HMJ, Haldorsen IS, Krakstad C. Berg A, et al. Oncotarget. 2017 Jul 31;8(40):68530-68541. doi: 10.18632/oncotarget.19708. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978135 Free PMC article.

7

HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.

Halle MK, Tangen IL, Berg HF, Hoivik EA, Mauland KK, Kusonmano K, Berg A, Hurtado A, Kalland KH, Øyan AM, Stefansson I, Vintermyr OK, Werner HM, Haldorsen IS, Trovik J, Salvesen HB, Krakstad C. Halle MK, et al. Among authors: berg a, berg hf. Br J Cancer. 2018 Feb 6;118(3):378-387. doi: 10.1038/bjc.2017.422. Epub 2017 Nov 23. Br J Cancer. 2018. PMID: 29169184 Free PMC article.

8

High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors.

Engerud H, Tangen IL, Berg A, Kusonmano K, Halle MK, Oyan AM, Kalland KH, Stefansson I, Trovik J, Salvesen HB, Krakstad C. Engerud H, et al. Among authors: berg a. Br J Cancer. 2014 Jul 8;111(1):78-84. doi: 10.1038/bjc.2014.262. Epub 2014 May 22. Br J Cancer. 2014. PMID: 24853175 Free PMC article.

9

Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.

Tangen IL, Werner HM, Berg A, Halle MK, Kusonmano K, Trovik J, Hoivik EA, Mills GB, Krakstad C, Salvesen HB. Tangen IL, et al. Among authors: berg a. Eur J Cancer. 2014 Nov;50(17):3003-10. doi: 10.1016/j.ejca.2014.09.003. Epub 2014 Sep 30. Eur J Cancer. 2014. PMID: 25281525

10

Androgen receptor as potential therapeutic target in metastatic endometrial cancer.

Tangen IL, Onyango TB, Kopperud R, Berg A, Halle MK, Øyan AM, Werner HM, Trovik J, Kalland KH, Salvesen HB, Krakstad C. Tangen IL, et al. Among authors: berg a. Oncotarget. 2016 Aug 2;7(31):49289-49298. doi: 10.18632/oncotarget.10334. Oncotarget. 2016. PMID: 27384477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,368 results

Search Page